Form 144 DEFINIUM THERAPEUTICS For: 25 March

📌 Key Takeaways

• A Form 144 was filed for Definium Therapeutics on March 25.
• The filing indicates a planned sale of securities by a company affiliate.
• Such forms are required for insiders intending to sell restricted stock.
• The filing does not confirm the sale was executed, only the intent.

🏷️ Themes

Financial Regulation, Biotechnology

Entity Intersection Graph

No entity connections available yet for this article.

Source

investing.com